using new data source https://howbad.info/essd.zip
This commit is contained in:
@@ -1 +1 @@
|
||||
{"Acute kidney injury ": 5.785850433581323, "Adenovirus infection ": 178.91709454538486, "Blood creatinine increased ": 5.193897657878051, "Cytomegalovirus colitis ": 162.29863038383192, "Cytomegalovirus infection ": 41.440928314154455, "Cytomegalovirus infection reactivation ": 66.90277757766741, "Disease progression ": 2.623364475754772, "Drug ineffective ": 4.648242467684529, "Drug ineffective for unapproved indication ": 66.20740585584294, "Drug resistance ": 66.19412812334754, "Graft versus host disease in gastrointestinal tract ": 145.9283893197127, "Haematuria ": 4.976482507869688, "Hemiparesis ": 11.18727847729707, "Multiple-drug resistance ": 60.847392246304615, "Myelosuppression ": 4.7153669730625785, "Nephropathy toxic ": 105.4011116265018, "Neutropenia ": 2.1392633581911373, "Off label use ": 8.175209875911749, "Pancytopenia ": 8.245672673576786, "Pathogen resistance ": 29.723942328537767, "Polyomavirus-associated nephropathy ": 175.93598661295954, "Product use in unapproved indication ": 4.559843719411307, "Product use issue ": 7.898429186621002, "Progressive multifocal leukoencephalopathy ": 88.93765803221706, "Renal failure ": 2.290129625039424, "Renal impairment ": 14.528366705436037, "Respiratory failure ": 7.203238343053603, "Uveitis ": 50.39468728080397}
|
||||
{"Actinic keratosis": 470.24417195106304, "Acute myocardial infarction": 2.949585464929604, "Anxiety": 5.495613911796524, "Basal cell carcinoma": 130.69036397828594, "Cardiac disorder": 7.922941329325782, "Coronary artery disease": 4.193942586660072, "Deafness": 2.872432561702933, "Depression": 6.547807783288016, "Diverticulitis": 2.856407711537741, "Drug effect less than expected": 45.5102683415831, "Drug interaction": 3.436527011346937, "Emotional distress": 9.361178518236857, "Erectile dysfunction": 15.25580309549722, "Erection increased": 10.493819189325457, "Feeling of despair": 34.36296800537022, "Gastrooesophageal reflux disease": 2.1911670814768214, "Hyperlipidaemia": 4.889486707741651, "Hypersensitivity": 2.733820285584924, "Intentional product misuse": 2.09179562207739, "Lentigo maligna": 1389.5915893463423, "Libido decreased": 14.529117802560044, "Libido increased": 56.07065819962056, "Lymphoedema": 8.494286139900328, "Malignant melanoma": 1030.757229570867, "Malignant melanoma in situ": 2984.2853286942864, "Malignant melanoma stage I": 10055.556989065251, "Malignant melanoma stage II": 6699.82115394077, "Malignant melanoma stage III": 3313.018374028092, "Malignant melanoma stage IV": 2615.4602735927106, "Melanocytic naevus": 55.802230110504254, "Melanoma recurrent": 467.9892252687633, "Metastases to liver": 3.038713415793136, "Metastatic malignant melanoma": 398.3852834812421, "Neoplasm progression": 3.9870605567468895, "Nephrolithiasis": 2.447686639967041, "Nodular melanoma": 683.7731034442445, "Prostate cancer": 14.872241062500802, "Pulmonary fibrosis": 4.237300140028569, "Sleep apnoea syndrome": 6.560609921974558, "Squamous cell carcinoma": 154.86879200899787, "Superficial spreading melanoma stage unspecified": 572.684034684605, "Therapeutic response unexpected": 5.395926926585034}
|
||||
Reference in New Issue
Block a user